Nextage Therapeutics (Israel) Top Management

MCTC Stock  ILA 37.70  1.30  3.33%   
Nextage Therapeutics employs about 6 people. The company is managed by 6 executives with a total tenure of roughly 23 years, averaging almost 3.0 years of service per executive, having 1.0 employees per reported executive. Analysis of Nextage Therapeutics' management performance can provide insight into the company performance.
Meir Yoeli  CEO
Chief Executive Officer
Guy Lerner  CEO
CEO
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nextage Therapeutics. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

Nextage Therapeutics Management Team Effectiveness

The company has return on total asset (ROA) of (0.3684) % which means that it has lost $0.3684 on every $100 spent on assets. This is way below average. Nextage Therapeutics' management efficiency ratios could be used to measure how well Nextage Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.

Nextage Therapeutics Workforce Comparison

Nextage Therapeutics is considered to be number one stock in number of employees category among related companies. The total workforce of Health Care industry is now estimated at about 16,705. Nextage Therapeutics adds roughly 6.0 in number of employees claiming only tiny portion of equities under Health Care industry.
The company has Profit Margin (PM) of (2.3) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (9.71) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $9.71.

Nextage Therapeutics Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Nextage Therapeutics Price Series Summation is a cross summation of Nextage Therapeutics price series and its benchmark/peer.

Nextage Therapeutics Notable Stakeholders

A Nextage Therapeutics stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Nextage Therapeutics often face trade-offs trying to please all of them. Nextage Therapeutics' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Nextage Therapeutics' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Meir YoeliChief Executive OfficerProfile
Guy LernerCEOProfile
Yifftach BielDeputy Vice President - FinanceProfile
Doron DebbieIndependent DirectorProfile
Itai BarNatanChief OfficerProfile
Yael GlickmanVP DevelProfile

About Nextage Therapeutics Management Performance

The success or failure of an entity such as Nextage Therapeutics often depends on how effective the management is. Nextage Therapeutics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Nextage management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Nextage management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Micromedic Technologies Ltd develops and commercializes in-vitro cancer diagnostic products and solutions worldwide. Further, the company provides diagnostic solutions for multiple cancer diagnostic applications. MICROMEDIC TECHNOL operates under Drug ManufacturersSpecialty Generic classification in Israel and is traded on Tel Aviv Stock Exchange.
The data published in Nextage Therapeutics' official financial statements usually reflect Nextage Therapeutics' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Nextage Therapeutics. For example, before you start analyzing numbers published by Nextage accountants, it's critical to develop an understanding of what Nextage Therapeutics' liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Nextage Therapeutics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Nextage Therapeutics' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Nextage Therapeutics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Nextage Therapeutics. Please utilize our Beneish M Score to check the likelihood of Nextage Therapeutics' management manipulating its earnings.

Nextage Therapeutics Workforce Analysis

Traditionally, organizations such as Nextage Therapeutics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Nextage Therapeutics within its industry.

Nextage Therapeutics Manpower Efficiency

Return on Nextage Therapeutics Manpower

Revenue Per Employee49.5K
Revenue Per Executive49.5K
Net Loss Per Employee348K
Net Loss Per Executive348K
Working Capital Per Employee166.7K
Working Capital Per Executive166.7K
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nextage Therapeutics. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Complementary Tools for Nextage Stock analysis

When running Nextage Therapeutics' price analysis, check to measure Nextage Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nextage Therapeutics is operating at the current time. Most of Nextage Therapeutics' value examination focuses on studying past and present price action to predict the probability of Nextage Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nextage Therapeutics' price. Additionally, you may evaluate how the addition of Nextage Therapeutics to your portfolios can decrease your overall portfolio volatility.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Please note, there is a significant difference between Nextage Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Nextage Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nextage Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.